The recently launched cobas pro integrated solutions is now available for countries accepting the CE mark. This next generation of innovation in the Serum Work Area improves operator experience to help streamline and simplify equipment and processes. With a  simple-to-use and newly designed interface, cobas pro integrated solutions allows for up to 2,200 tests per hour with three modules working in parallel and perfectly synchronized in order to improve efficiency. Furthermore, it boasts up to 3.25 hours less operating time, while 93% of Roche Immunoassays have reaction times of 18 minutes or less. The new cobas pro integrated solutions offers several advanced features, including automated maintenance and cobas AutoCal, together with an intelligent, on-the-fly reagent loading concept. These features aim to optimize the day-to-day experience of laboratory professionals, reducing the time they spend on manual operations. cobas pro integrated solutions introduce key innovations including cobas SonicWash, which is an ultrasonic probe cleaning on the Clinical Chemistry and Ion-Selective Electrode analytical units which assures sample integrity, as well as efficient and flexible sample routing; together with the cobas AutoCal, which is an automated calibration procedure on the clinical chemistry analytical unit which saves precious hands-on time.

Read more

Beckman Coulter Diagnostics has announced achievement of CE Mark of its DxH 520 hematology analyser, designed to help physician office laboratories deliver high-quality results with increased productivity and ease. With as little as two environmentally friendly reagents, the compact 5-part differential system enhances efficiency and resource management through a comprehensive feature set that automates daily tasks. This reduces the amount of time spent on laboratory operations and frees time for patient care. The company used its time-proven flagship DxH 800 hematology solution as the predicate method for the DxH 520 system, establishing a strong correlation throughout the entire DxH line of hematology analysers. This provides a high level of continuity of care for clinical laboratories, regardless of whether they are small- or high-volume facilities. The DxH 520 analyser fills a need for a comprehensive solution that increases productivity while driving down costs for physician office laboratories. It features proprietary dynamic-gating method that improves sample flagging, and reduces slide reviews and technical interpretation, while maintaining effective clinical sensitivity. As an upgrade from a 3-part to a 5-part differential instrument, the DxH 520 analyser gives the clinician more information by which to make decisions when assessing a patient. A robust IT and data-management package helps reduce clerical errors and inefficiencies, and allows for easy retrieval of up to 30,000 patient samples. The system’s small 17 µL aspiration is ideal for puncture samples from infants, geriatric, oncology and critical care patients. Closed tube aspiration capability both simplifies analysis and ensures safety for laboratory technologists by eliminating sample exposure. The easy-to-use interface enables technologists to access any screen in three clicks or less, saving valuable time. The system’s two reagents and on-board cleaner can be replaced in five minutes or less, and its aqueous-based cyanide-, azide- and formaldehyde-free reagents eliminates disposal costs. This is in contrast to competitive systems that use five or more reagents— many of which are primarily composed of organic solvents that require additional costly disposal fees. The analyser’s low-energy requirements – half the power demand of other analysers in its category – further lower operating costs.

Read more

Chromsystems has launched the first CE-IVD validated HPLC assay for antibiotics. It allows the quantitative determination of ampicillin, cefepime, ceftazidime, linezolid, meropenem and piperacillin in human serum and plasma. The assay is used to monitor the blood levels of these antibiotics and also provides qualitative data for sulbactam and tazobactam. The exceptional high stability of calibrators and controls as well as two internal standards ensure a precise quantification. The assay also includes a Priming Solution that increases the stability of the patient samples. The HPLC determination with subsequent UV detection is divided into two groups and requires only one column and one sample prep for all parameters.

Read more

The new generation of the popular automated urinalysis system that combines a urine chemistry analyser and a urine sediment analyser is introduced. The LabUMat 2 is a high-throughput, automated urine chemistry analyser that is able to evaluate 10 chemical and 3 physical parameters of urine samples. The UriSed 3 PRO is an automated urine sediment analyser with a novel optical system combining bright-field and phase contrast microscopy, detecting 18 sediment particle types without the need of any liquid reagents. The efficiencies of the LabUMat 2 and the UriSed 3 PRO are maximized when these instruments are used as one walk-away system dealing with the workload of big laboratories. The automated technology improves diagnostic quality by increased reproducibility and accuracy and also improves productivity by eliminating the time-consuming procedure of manual sample preparation.

Read more

Randox partners with Bosch to launch ‘Vivalytic’, the all-in-one fully automated solution for molecular diagnostics. Using Randox-patented Biochip Array Technology, Vivalytic is the easiest to use and most comprehensive multiplex PCR platform on the market. The device also supports single-plex and low-plex testing, simplifying the processes for otherwise complex laboratory test procedures. Depending on the test application, results will be delivered from 30 minutes. The first tests available on the Vivalytic are Randox’s panels for respiratory and sexually-transmitted infections (CE and FDA pending). The Respiratory Multiplex Array simultaneously detects 22 viral and bacterial pathogens including Bordetella parapertussis – without the need for secondary or confirmatory
testing to inform clinical treatment decisions. The STI (Sexually-Transmitted Infections) array enables the detection of 10 viral, bacterial and protozoan STIs from a single urine or urogenital swab sample. Every day more than 1 million STIs are acquired and many have no symptoms or only mild ones which may not be recognized as an STI. Chlamydia trachomatis, N. gonorrhoeae, Trichomonas vaginalis, and Treponema pallidum, all of which can be detected on the biochip, are among the most common causes. Identifying these infections correctly first time reduces the misuse of antibiotics and supports their targeted use, while saving costs associated with single infection detection.

Read more